Matthew Edward Ryan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthew Edward Ryan has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jason C. Fleming
Liverpool Head and Neck Centre, Head and Neck Surgery, Liverpool University Hospitals NHS Foundation Trust Aintree Hospital, Liverpool, UK
3 shared publications Ava Gubbay
School of Medicine University of Liverpool Liverpool UK
1 shared publication- Christopher Loh
Department of Head and Neck Surgery Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust Liverpool UK
1 shared publication Faheema I. Sidat
School of Medicine Faculty of Health and Life Sciences, University of Liverpool Liverpool L69 3GE UK
1 shared publicationHarishanker Jeyarajan
Department of Otolaryngology—Head and Neck Surgery The University of Alabama at Birmingham Birmingham Alabama USA
1 shared publicationKatharine Davies
Department of Head and Neck Surgery Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust Liverpool UK
1 shared publication
Latest Publications
- Open Access
- 8 October 2026
- Published by Wiley in Clinical Otolaryngology
da Vinci Single‐Port Transoral Robotic Surgery in European Practice: Early Outcomes and Comparison With Transoral Laser Microsurgery
Objectives: To report early outcomes following implementation of a da Vinci Single‐Port transoral robotic surgery (SP‐TORS) programme in the United Kingdom. To provide contextual benchmarking, outcomes were compared with a historical institutional cohort treated using transoral laser microsurgery (TLM). Design: Retrospective institutional series with comparison against a historical cohort using stabilised inverse‐probability‐of‐treatment weighting. Setting: High‐volume UK Tertiary Head and Neck Centre. Participants: All patients undergoing SP‐TORS between April 2024 and September 2025. Comparative analyses were limited to oncological resections and included 33 SP‐TORS and 61 TLM cases. Main Outcome Measures: Feasibility, peri‐operative safety, postoperative haemorrhage, return to theatre, mortality, length of stay, time to oral diet, margin status and adjuvant therapy use. Results: Sixty‐six patients underwent SP‐TORS. All procedures were completed transorally without unplanned conversion or peri‐operative mortality. Postoperative haemorrhage occurred in 4.5%, with one return to theatre. Length of stay did not differ between groups. Time to oral diet was longer following SP‐TORS (adjusted ratio 1.51, p = 0.005). ASCO‐defined involved margins were similar (OR 0.30, 95% CI 0.06–1.56; p = 0.15), whereas specimen ink‐positive margins were less frequent following SP‐TORS (OR 0.31, 95% CI 0.11–0.91; p = 0.03). A sensitivity analysis using propensity‐matched T1/T2 pairs demonstrated a consistent directional effect, though this did not reach significance in the smaller matched cohort. Adjuvant therapy use was comparable. Conclusion: SP‐TORS implementation in a high‐volume UK centre was feasible and safe during early adoption, with low complication rates. Peri‐operative and early functional outcomes were broadly comparable with TLM. Although specimen ink‐positive margins were less frequent following SP‐TORS, interpretation should be cautious given the historical comparator and associated differences in departmental workflow. These findings support safe integration of SP‐TORS into transoral surgical practice and justify prospective evaluation.
- 8 October 2026
- Published by Wiley in Clinical Otolaryngology
Open Accessda Vinci Single‐Port Transoral Robotic Surgery in European Practice: Early Outcomes and Comparison With Transoral Laser Microsurgery
Objectives: To report early outcomes following implementation of a da Vinci Single‐Port transoral robotic surgery (SP‐TORS) programme in the United Kingdom. To provide contextual benchmarking, outcomes were compared with a historical institutional cohort treated using transoral laser microsurgery (TLM). Design: Retrospective institutional series with comparison against a historical cohort using stabilised inverse‐probability‐of‐treatment weighting. Setting: High‐volume UK Tertiary Head and Neck Centre. Participants: All patients undergoing SP‐TORS between April 2024 and September 2025. Comparative analyses were limited to oncological resections and included 33 SP‐TORS and 61 TLM cases. Main Outcome Measures: Feasibility, peri‐operative safety, postoperative haemorrhage, return to theatre, mortality, length of stay, time to oral diet, margin status and adjuvant therapy use. Results: Sixty‐six patients underwent SP‐TORS. All procedures were completed transorally without unplanned conversion or peri‐operative mortality. Postoperative haemorrhage occurred in 4.5%, with one return to theatre. Length of stay did not differ between groups. Time to oral diet was longer following SP‐TORS (adjusted ratio 1.51, p = 0.005). ASCO‐defined involved margins were similar (OR 0.30, 95% CI 0.06–1.56; p = 0.15), whereas specimen ink‐positive margins were less frequent following SP‐TORS (OR 0.31, 95% CI 0.11–0.91; p = 0.03). A sensitivity analysis using propensity‐matched T1/T2 pairs demonstrated a consistent directional effect, though this did not reach significance in the smaller matched cohort. Adjuvant therapy use was comparable. Conclusion: SP‐TORS implementation in a high‐volume UK centre was feasible and safe during early adoption, with low complication rates. Peri‐operative and early functional outcomes were broadly comparable with TLM. Although specimen ink‐positive margins were less frequent following SP‐TORS, interpretation should be cautious given the historical comparator and associated differences in departmental workflow. These findings support safe integration of SP‐TORS into transoral surgical practice and justify prospective evaluation.
- 4 May 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
Contrast Swallow for Detecting Pharyngocutaneous Fistula After Total Laryngectomy: A Systematic Review
Objective: To evaluate the diagnostic performance of contrast swallow utilised to identify pharyngocutaneous fistula (PCF) following laryngectomy. Data Sources: A systematic search of databases was conducted (MEDLINE, EMBASE, and PubMed). Review Methods: Studies including adult patients (≥18 years old) who had undergone total laryngectomy (salvage or primary) or pharyngolaryngectomy and had postoperative diagnostic imaging of any modality (eg, ultrasound, CT, MRI) performed to assess for presence of PCF were eligible for inclusion. The diagnostic accuracy (ie sensitivity, specificity, etc.) for identifying PCF was extracted. Results: A total of 13 studies involving 1456 patients recruited across a 43‐year period from (1979 to 2022) were included. Diagnostic accuracy ranges of contrast swallow were reported as a sensitivity of 0.26 to 1.00, specificity of 0.55 to 0.99 and positive and negative predictive values of 0.14 to 0.85 and 0.75 to 1.00 respectively. Conclusions: The accuracy of contrast swallow as a screening tool in detecting PCF varies significantly in the reported studies with overall poor performance. Studies displayed a varied positive predictive value range, with a high number of false positives potentially causing unwarranted delays in commencing oral feeding. Positive predictive values must be interpreted cautiously given the literatures variation of how pharyngeal leaks were managed, potentially preventing progression to clinical PCF. While the heterogenicity within the data from the studies prevents definitive conclusions, the review calls into question the utility of the contrast swallow and highlights the need for more superior diagnostic pathways.
- 4 May 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
Contrast Swallow for Detecting Pharyngocutaneous Fistula After Total Laryngectomy: A Systematic Review
Objective: To evaluate the diagnostic performance of contrast swallow utilised to identify pharyngocutaneous fistula (PCF) following laryngectomy. Data Sources: A systematic search of databases was conducted (MEDLINE, EMBASE, and PubMed). Review Methods: Studies including adult patients (≥18 years old) who had undergone total laryngectomy (salvage or primary) or pharyngolaryngectomy and had postoperative diagnostic imaging of any modality (eg, ultrasound, CT, MRI) performed to assess for presence of PCF were eligible for inclusion. The diagnostic accuracy (ie sensitivity, specificity, etc.) for identifying PCF was extracted. Results: A total of 13 studies involving 1456 patients recruited across a 43‐year period from (1979 to 2022) were included. Diagnostic accuracy ranges of contrast swallow were reported as a sensitivity of 0.26 to 1.00, specificity of 0.55 to 0.99 and positive and negative predictive values of 0.14 to 0.85 and 0.75 to 1.00 respectively. Conclusions: The accuracy of contrast swallow as a screening tool in detecting PCF varies significantly in the reported studies with overall poor performance. Studies displayed a varied positive predictive value range, with a high number of false positives potentially causing unwarranted delays in commencing oral feeding. Positive predictive values must be interpreted cautiously given the literatures variation of how pharyngeal leaks were managed, potentially preventing progression to clinical PCF. While the heterogenicity within the data from the studies prevents definitive conclusions, the review calls into question the utility of the contrast swallow and highlights the need for more superior diagnostic pathways.
- Open Access
- 9 June 2023
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 27 (13) , 1763-1774
The molecular and clinical role of Tensin 1/2/3 in cancer
Tensin 1 was originally described as a focal adhesion adaptor protein, playing a role in extracellular matrix and cytoskeletal interactions. Three other Tensin proteins were subsequently discovered, and the family was grouped as Tensin. It is now recognized that these proteins interact with multiple cell signalling cascades that are implicated in tumorigenesis. To understand the role of Tensin 1–3 in neoplasia, current molecular evidence is categorized by the hallmarks of cancer model. Additionally, clinical data involving Tensin 1–3 are reviewed to investigate the correlation between cellular effects and clinical phenotype. Tensin proteins commonly interact with the tumour suppressor, DLC1. The ability of Tensin to promote tumour progression is directly correlated with DLC1 expression. Members of the Tensin family appear to have tumour subtype‐dependent effects on oncogenesis; despite numerous data evidencing a tumour suppressor role for Tensin 2, association of Tensins 1–3 with an oncogenic role notably in colorectal carcinoma and pancreatic ductal adenocarcinoma is of potential clinical relevance. The complex interplay between these focal adhesion adaptor proteins and signalling pathways are discussed to provide an up to date review of their role in cancer biology.
- 9 June 2023
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 27 (13) , 1763-1774
Open AccessThe molecular and clinical role of Tensin 1/2/3 in cancer
Tensin 1 was originally described as a focal adhesion adaptor protein, playing a role in extracellular matrix and cytoskeletal interactions. Three other Tensin proteins were subsequently discovered, and the family was grouped as Tensin. It is now recognized that these proteins interact with multiple cell signalling cascades that are implicated in tumorigenesis. To understand the role of Tensin 1–3 in neoplasia, current molecular evidence is categorized by the hallmarks of cancer model. Additionally, clinical data involving Tensin 1–3 are reviewed to investigate the correlation between cellular effects and clinical phenotype. Tensin proteins commonly interact with the tumour suppressor, DLC1. The ability of Tensin to promote tumour progression is directly correlated with DLC1 expression. Members of the Tensin family appear to have tumour subtype‐dependent effects on oncogenesis; despite numerous data evidencing a tumour suppressor role for Tensin 2, association of Tensins 1–3 with an oncogenic role notably in colorectal carcinoma and pancreatic ductal adenocarcinoma is of potential clinical relevance. The complex interplay between these focal adhesion adaptor proteins and signalling pathways are discussed to provide an up to date review of their role in cancer biology.